Search Results - Fenor De La Maza, M.D.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    P1.01-057 Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

    P1.01-057 Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) by Rogado, J., Pacheco-Barcia, V., Fenor De La Maza, M.D., Serra, J.M., Toquero, P., Vera, B., Obispo, B., Mondéjar, R., Ballesteros, A., Donnay, O., Colomer, R., Sánchez-Torres, J.M.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P2.02-027 Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

    P2.02-027 Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)? by Rogado, J., De La Maza, M.D. Fenor, Pacheco-Barcia, V., Serra, J.M., Toquero, P., Vera, B., Ballesteros, A., Mondéjar, R., Donnay, O., Obispo, B., Colomer, R., Sánchez-Torres, J.M.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: